: Management Discussion and Analysis For the year ended December 31, 2018 Summary of Performance Sales Revenue For the year ended 31 December 2017 and 2018, the Company registered total sales revenue of THB

as follows: Management Discussion and Analysis For the six months period ended June 30, 2018 Results of Operations Sales Revenue For the six months period ended 30 June 2017 and 2018, the Company’s

30, 2018 as follows: Management Discussion and Analysis For the nine months period ended September 30, 2018 Results of Operations Sales Revenue For the nine months period ended 30 September 2017 and

, 2018 as follows: Management Discussion and Analysis For the three months period ended March 31, 2018 Results of Operations Sales Revenue For the three months period ended March 31, 2017 and 2018. Our

drug stores. 2,299.7 2,407.6 2,076.2 126.2 148.6 134.9 2,426.0 2,556.2 2,211.1 -400 100 600 1,100 1,600 2,100 2,600 Q1/19 Q4/19 Q1/20 Revenue from Sale of Goods Revenue from Rental and Rendering of

additional revenue that more or less fulfill the loss of regular hospital revenue. Furthermore, the Company has implemented cost saving measures to maintain its operating results for continuous growth. In

Pattana”) in 1Q20 shows total revenue of THB 11,423 mn and net profit stood at THB 4,592 mn, mainly influenced by non-recurring items as well as revenue from residential business together with cost

. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition

persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator

transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging